FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE

Post-LOE

famotidine, calcium carbonate and magnesium hydroxide

Design Pharmaceuticals

ANDAORALTABLET, CHEWABLE

Approved

Feb 2008

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE (famotidine, calcium carbonate and magnesium hydroxide) by Design Pharmaceuticals is histamine h2 receptor antagonists [moa]. Approved for heartburn associated with acid indigestion, sour stomach. First approved in 2008.

Drug data last refreshed 21h ago

Mechanism of Action

Histamine H2 Receptor Antagonists

Pharmacologic Class:

Histamine-2 Receptor Antagonist

Indications (2)

heartburn associated with acid indigestion sour stomach

Worked on FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.